<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02692235</url>
  </required_header>
  <id_info>
    <org_study_id>2014/15/B/NZ7/00893</org_study_id>
    <nct_id>NCT02692235</nct_id>
  </id_info>
  <brief_title>Carnitine Supplementation and Skeletal Muscle Function</brief_title>
  <official_title>Carnitine Supplementation and Skeletal Muscle Function in Aging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gdansk University of Physical Education and Sport</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gdansk University of Physical Education and Sport</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Research project objectives

      The primary aims of the current research project are:

        1. To investigate the effects of carnitine with leucine supplementation, in comparison to
           carnitine supplementation alone, on muscle strength and body composition;

        2. To use carnitine supplementation as the anti-inflammatory intervention for exploring the
           relationship between inflammation and associated with aging reduction of skeletal muscle
           mass;

        3. To explore whether nutritional supplementation and resistance training might be combined
           to produce synergistic effects in prevention of muscle loss during aging;

      Hypothesis

        1. Leucine stimulates carnitine transport into the muscle cells, which improve
           mitochondrial capacity. Modification in energetic of skeletal muscle affects the body
           composition and muscle performance;

        2. The carnitine supplementation modulates the blood cytokines concentration.
           Anti-inflammatory intervention delay the reduction of skeletal muscle mass associated
           with aging;

        3. Resistance training combined with nutritional supplementation have more beneficial
           effect than resistance training alone in prevention of muscle loss during aging;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The project is separated on two studies. Study A: young volunteers (n=40) are supplemented
      either with carnitine with leucine or carnitine alone for 24 weeks. Before the start, in the
      mid-point, and after finishing the supplementation the following primary outputs variables
      are performed: maximal isokinetic knee extensor peak torque (Biodex System 4 Pro), body
      composition analysis (InBody720), skeletal muscle carnitine concentration, oral glucose
      tolerance test. Study B: volunteers over 65 years old (n=40) are supplemented either with
      carnitine or placebo for 24 weeks. Before the start, in the mid-point, and after finishing
      the supplementation the following primary outputs variables are performed: body composition
      analysis, blood cytokines and carnitine concentration, blood lipid profile and global
      physical activity questionnaire.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Actual">July 2017</completion_date>
  <primary_completion_date type="Actual">July 2017</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood inflammatory markers</measure>
    <time_frame>baseline and 24 weeks</time_frame>
    <description>Change in blood inflammatory markers</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Metabolism</measure>
    <time_frame>baseline and 24 weeks</time_frame>
    <description>Change in blood metbolites</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Carnitine transport to skeletal muscle cells</measure>
    <time_frame>baseline and 24 weeks</time_frame>
    <description>Change in skeletal muscle carnitine concentration</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Sarcopenia</condition>
  <arm_group>
    <arm_group_label>carnitine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>24 weeks l-carnitine-l-tartrate supplementation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>leucine</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>24 weeks l-leucine supplementation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>carnitine &amp; leucine</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>24 weeks of l-carnitine-l-tartrate in combination with l-leucine supplementation</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>carnitine</intervention_name>
    <description>1500 mg/d l-carnitine-l-tartrate</description>
    <arm_group_label>carnitine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>leucine</intervention_name>
    <description>1500 mg/d l-leucine</description>
    <arm_group_label>leucine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>carnitine &amp; leucine</intervention_name>
    <description>2000 mg/d l-carnitine-l-tartrate and 4000 mg/d l-leucine</description>
    <arm_group_label>carnitine &amp; leucine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects with no history of gastrointestinal disorders, cardiovascular disease or
             hypertension.

        Exclusion Criteria:

          -  Subjects having any illnesses and a history of gastrointestinal disorder,
             cardiovascular disease, hypertension, liver and renal disease, diabetes, cancer,
             alcoholism or other metabolic diseases.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert A Olek, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gdansk University of Physical Education and Sport</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Physical Education and Sport</name>
      <address>
        <city>Gdansk</city>
        <state>Pomorskie</state>
        <zip>80-336</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 13, 2016</study_first_submitted>
  <study_first_submitted_qc>February 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 26, 2016</study_first_posted>
  <last_update_submitted>July 1, 2017</last_update_submitted>
  <last_update_submitted_qc>July 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gdansk University of Physical Education and Sport</investigator_affiliation>
    <investigator_full_name>Robert Olek</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>carnitine</keyword>
  <keyword>leucine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcopenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>July 17, 2017</submitted>
    <returned>August 15, 2017</returned>
    <submitted>March 1, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

